Lanzol (Lansoprazole)

Lanzol, a proton pump inhibitor, acts on the gastric acid secretion pathway to treat acid‑related disorders.

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of esophageal irritation.
• Peptic ulcer disease: accelerates ulcer healing and reduces recurrence.
• NSAID‑induced gastric ulcer: prevents ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.
• Helicobacter pylori eradication (in combination therapy): enhances the success of eradication regimens when used with antibiotics.

• Lansoprazole irreversibly binds to the H+/K+ ATPase enzyme (proton pump) located on gastric parietal cells. By inhibiting this final step of acid secretion, it markedly lowers gastric acidity, allowing the mucosal lining to heal and reducing reflux‑related symptoms. The inhibition persists until new proton pumps are synthesized, providing prolonged acid suppression.

Lanzol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Headache: mild to moderate pain in the head.
• Diarrhea: loose, frequent stools.
• Abdominal pain: discomfort or cramping in the stomach area.
• Nausea: feeling of unease and urge to vomit.
• Flatulence: excess gas in the digestive tract.
• Constipation: difficulty passing stools.

Serious or Rare Side Effects

• Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing.
• Clostridioides difficile infection: severe colitis with watery diarrhea.
• Stevens‑Johnson syndrome: painful skin blistering and detachment.
• Elevated liver enzymes: signs of hepatic stress.
• Hypomagnesemia: low magnesium levels with long‑term use.
• Bone fractures: increased risk with prolonged therapy.

Before prescribing Lanzol, clinicians should consider several safety aspects.

• Assess renal function: adjust therapy in patients with severe impairment.
• Monitor for infection: increased risk of Clostridioides difficile colitis.
• Check magnesium levels: long‑term use may cause hypomagnesemia.
• Review concomitant antiretrovirals: may reduce their effectiveness.
• Pregnancy: use only when the potential benefit justifies the potential risk.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Lanzol can affect the pharmacokinetics of several medicines; interactions vary in clinical significance.

Major Interactions (Avoid)

• Ketoconazole: reduced absorption of ketoconazole.
• Atazanavir: decreased plasma concentrations of atazanavir.
• Clopidogrel: diminished activation of clopidogrel.
• Warfarin: potential increase in INR and bleeding risk.
• Methotrexate: heightened toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely)

• Diazepam: possible increase in serum levels.
• Digoxin: may raise digoxin concentrations.
• Phenytoin: potential reduction in phenytoin levels.